Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)

NCT07725926 is registered in ClinicalTrials.gov with University College London Hospitals as lead sponsor.

NCT NCT07725926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07725926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)
Lead sponsor
University College London Hospitals
Phase
Not applicable
Overall status
Recruiting
Start date
July 8, 2026
Completion date
February 1, 2030
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gilles de la tourette syndrome, obsessive - compulsive disorder, tic disorder, chronic motor or vocal, tic disorder, combined vocal and multiple motor, tic disorders, tourette disease, tourette disorder, tourettes syndrome